Healthcare CRO Services Market in Europe is expected to register a CAGR of 5.9% during the forecast period (2019-2025) - KBV Research

16-Apr-2020 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report Europe Healthcare CRO Services Market, published by KBV research, the Europe Healthcare CRO Services Market would witness market growth of 5.9% CAGR during the forecast period (2019-2025).

The Germany market dominated the Europe Academic Institutes Market by Country 2018, growing at a CAGR of 7.4 % during the forecast period. The UK market is exhibiting a CAGR of 7.6% during (2019 - 2025). Additionally, The France market is poised to grow at a CAGR of 9.6% during (2019 - 2025).

The Clinical Research Services market dominated the France Healthcare CRO Services Market by Service Type 2018, thereby, achieving a market value of $1,078.8 million by 2025, growing at a CAGR of 5.9 % during the forecast period. The Early Phase Development market is experiencing a CAGR of 6.1% during (2019 - 2025). Additionally, The Laboratory Services market is expected to witness CAGR of 7.8% during (2019 - 2025).

The Oncology market dominated the Spain Healthcare CRO Services Market by Therapeutic Areas 2018, growing at a CAGR of 5.2 % during the forecast period. The CNS Disorder market is estimated to grow at a CAGR of 5.7% during (2019 - 2025). The Cardiovascular Disease market witnessing a CAGR of 7.8% during (2019 - 2025). Additionally, The Diabetes market is expected to witness CAGR of 7.1% during (2019 - 2025).

Structural Insights: https://www.kbvresearch.com/europe-healthcare-cro-services-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of IQVIA Holdings, Inc., Laboratory Corporation of America Holdings (Covance, Inc.), Pharmaceutical Product Development, Inc., Parexel International Corporation (Pamplona Capital Management), Charles River Laboratories International, Inc., ICON PLC, Dassault Systemes SE (Medidata Solutions, Inc.), Syneos Health, Inc., Pharmaron Beijing Co., Ltd., and GVK Biosciences Private Limited.